Ingevity (NGVT) Cost of Revenue (2015 - 2026)

Ingevity (NGVT) has 12 years of Cost of Revenue data on file, last reported at $141.6 million in Q1 2026.

• Quarterly Cost of Revenue rose 4.12% year-over-year to $141.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $735.3 million (down 4.38% YoY) and the FY2025 annual result came in at $706.1 million, down 3.97% from the prior year.
• Cost of Revenue fell to $141.6 million in Q1 2026 per NGVT's latest filing, from $167.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $328.8 million in Q2 2023 and bottomed at -$137.5 million in Q4 2023.
• The 5-year median for Cost of Revenue is $240.4 million (2024), against an average of $212.6 million.
• The widest annual swing landed in 2023, when Cost of Revenue sank 149.42%; it then soared 218.84% in 2024.
• Tracing NGVT's Cost of Revenue over 5 years: stood at $278.2 million in 2022, then slumped by 149.42% to -$137.5 million in 2023, then soared by 218.84% to $163.4 million in 2024, then advanced by 2.39% to $167.3 million in 2025, then retreated by 15.36% to $141.6 million in 2026.
• Per Business Quant, the three latest NGVT Cost of Revenue figures stand at $141.6 million (Q1 2026), $167.3 million (Q4 2025), and $199.2 million (Q3 2025).

Peer Comparison